Impact of HIV infection on the recurrence of tuberculosis in south india

Journal of Infectious Diseases

Volumn 201, Issue 5, 2010, Pages 691-703

  Narayanan, Sujatha ^a   Swaminathan, Soumya ^a   Supply, Philip ^b   Shanmugam, Sivakumar ^a   Narendran, Gopalan ^a   Hari, Lalitha ^a   Ramachandran, Ranjani ^a   Locht, Camille ^b   Jawahar, Mohideen Shaheed ^a   Narayanan, Paranji Raman ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b INSTITUT DE BIOLOGIE DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ARTICLE; DNA FINGERPRINTING; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; POSTPRIMARY TUBERCULOSIS; PRIORITY JOURNAL; RECURRENT INFECTION; REINFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SHORT COURSE THERAPY; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; BACTERIAL TYPING TECHNIQUES; DNA FINGERPRINTING; DNA, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; INDIA; MALE; MYCOBACTERIUM TUBERCULOSIS; RECURRENCE; TUBERCULOSIS;

EID: 76449091261     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/650528     Document Type: Article

References (40)

1. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003; 362:887-899.
2. Harries AD, Hargreaves NJ, Kemp J, et al. Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet 2001; 357:1519-1523.
3. UNAIDS/WHO. Report on the global AIDS epidemic. July 2008. http:// data.unaids.org/pub/GlobalReport/2008/JC1511-GR08-Executive Summary-en.pdf. Accessed 3 March 2009.
4. World Health Organization. WHO report 2008.Global tuberculosis control: surveillance, planning, financing. http://www.who.int/tb/ publications/global- report/2008/pdf/fullreport.pdf. Accessed 3 March 2009.
5. Sharma SK, Alladi Mohan, Tamilarasu Kadhiravan. HIV-TB co-infection: epidemiology, diagnosis, and management. Indian J Med Res 2005; 121:550-567.
6. Swaminathan S, Ramachandran R, Baskaran G, et al. Risk of development of tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis 2000; 4:839-844.
7. El-Sadr WM, Perlman DC, Denning E, Matts JP, Cohn DL. A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes. Clin Infect Dis 2001; 32:623-632.
8. Lambert M-L, Hasker E, van Deun A, Roberfroid D, Boelaert M, van der Stuyft P. Recurrence in tuberculosis: relapse or re-infection? Lancet Infect Dis 2003; 3:282-287.
9. Cacho J, Pérez Meixeira A, Cano I, et al. Recurrent tuberculosis from 1992 to 2004 in a metropolitan area. Eur Respir J 2007; 30:333-337.
10. Narayanan S, Das S, Garg R, Hari L, Bhaskara Rao V, Frieden TR, Narayanan PR. Molecular epidemiology of tuberculosis in a rural area of high prevalence in South India: implications for disease control and prevention. J Clin Microbiol 2002; 40:4785-4788.
11. Charalambous S, Grant AD, Moloi V, et al. Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung Dis 2008; 12:942-948.
12. Golub JE, Durovni B, King BS, et al. Recurrent tuberculosis in HIVinfected patients in Rio de Janeiro, Brazil. AIDS 2008; 22:2527-2533.
13. Swaminathan S, Narendran G, Venkatesan P, et al. Efficacy of 6-month vs 9-month intermittent treatment regimens in HIV-infected tuberculosis patients: a randomized clinical study. Am J Respir Crit Care Med doi:10.1164/rccm.200903- 0439OC. Published 3 December 2009.
14. Tuberculosis Research Centre. Shortening short course chemotherapy: a randomized clinical trial for the treatment of smear positive pulmonary tuberculosis with regimens using ofloxacin in the intensive phase. Indian J Tuberc 2002; 49:27-38.
15. Swaminathan S, Paramasivan C N, Ponnuraja C, Iliayas S, Rajasekaran S, Narayanan P R, Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India. Int J Tuberc Lung Dis 2005; 9: 896-900.
16. Baess I. Isolation and purification of deoxyribonucleic acid from Mycobacteria. Acta Pathol Microbiol Scand [B] Microbiol Immunol 1974; 82:780-784.
17. Van Embden JD, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31:406-409.
18. Kremer K, van Soolingen D, Frothingham R, et al. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol 1999; 37:2607-2618.
19. Supply P, Allix C, Lesjean S, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2006; 44:4498-4510.
20. Concheiro M, Samper S, Gavin P, Martin C. Recurrent tuberculosis from 1992 to 2004 in a metropolitan area. Eur Respir J 2007; 30:333-337.
21. Bandera A, Gori A, Catozzi L, et al. Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol 2001; 39:2213-2218.
22. Small PM, Shafer RW, Hopewell PC, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993; 328:1137-1144.
23. Caminero JA, Pena MJ, Campos-Herrero MI, et al. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am J Respir Crit Care Med 2001; 163:717-720.
24. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bulletin of theWorld Health Organization 1994; 72:213-220. (Pubitemid 24156209)
25. Hopewell PC. The impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis 1992; 15:540-547.
26. Sahadevan R, Narayanan S, Paramasivan CN, Prabhakar R, Narayanan PR. Restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, India, by use of direct-repeat probe. J Clin Microbiol 1995; 33:3037-3039.
27. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey- Faussett P. HIV-1 and recurrence, relapse, and re-infection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001; 358:1687-1693.
28. Nahid P, Gonzalez LC, Rudoy I, et al. Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med 2007; 175:1199-1206.
29. Chiang CY, Riley LW. Exogenous re-infection in tuberculosis. Lancet Infect Dis 2005; 5:629-636.
30. Sun YJ, Lee AS, Ng ST, et al. Characterization of ancestral Mycobacterium tuberculosis by multiple genetic markers and proposal of genotyping strategy. J Clin Microbiol 2004; 42:5058-5064.
31. Sola C, Filliol I, Legrand E, et al. Genotyping of the Mycobacterium tuberculosis complex using MIRUs: association with VNTR and spoligotyping for molecular epidemiology and evolutionary genetics. Infect Genet Evol 2003; 3:125-133.
32. Narayanan S, Gagneux S, Hari L, et al. Genomic interrogation of ancestral Mycobacterium tuberculosis from south India. Infect Genet Evol 2008; 8:474-483.
33. Singh UB, Suresh N, Bhanu NV, et al. Predominant tuberculosis spoligotypes, Delhi, India. Emerg Infect Dis 2004; 10:1138-1142.
34. Korenromp EL, Scano F,Williams BG, Dye C, Nunn P. Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifamycin based treatment: an analytical review. Clin Infect Dis 2003;37: 101-112.
35. Sterling TR, Alwood K, Gachuhi R, et al. Relapse rates after short course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons. AIDS 1999; 13:1899-1904.
36. Swaminathan S, Deivanayagam CN, Rajasekaran S, et al. Long-term follow up of HIV-infected TB patients treated with 6-month intermittent short course chemotherapy. Natl Med J India 2008; 21:3-8.
37. Thomas A, Gopi PG, Santha T, et al. Predictors of relapse among pulmonary tuberculosis patients treated in aDOTS programme in South India. Int J Tuberc Lung Dis 2005; 9:556-561.
38. Spiegelman MK. New tuberculosis therapy: a growing pipeline. J Infect Dis 2007; 196:S28-S34.
39. Harries AD, Zachariah R, Lawn SD. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa. Int J Tuberc Lung Dis 2009; 13:6-16.
40. Churchyard GJ, Fielding K, Charalambous S, et al. Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy? AIDS 2003; 17:2063-2070.